ICM

  • Biotech or pharma, therapeutic R&D

ICM is a South Korean company that uses AAV gene therapy platform to develop treatments for several diseases. These include osteoarthritis (OA), degenerative retina diseases including AMD (Age-related Macular Degeneration), and sensorineural hearing loss (PDS/DFNB4).

Address

Seoul
South Korea

Website

http://icm-bio.com/en/index.asp

Contact Exhibitor


Loading
View all Partnering Companies

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS